BDNF interacts with endocannabinoids to regulate cocaine-induced synaptic plasticity in mouse midbrain dopamine neurons

J Neurosci. 2015 Mar 11;35(10):4469-81. doi: 10.1523/JNEUROSCI.2924-14.2015.

Abstract

Brain-derived neurotrophic factor (BDNF) and endocannabinoids (eCBs) have been individually implicated in behavioral effects of cocaine. The present study examined how BDNF-eCB interaction regulates cocaine-induced synaptic plasticity in the ventral tegmental area and behavioral effects. We report that BDNF and selective tyrosine kinase receptor B (TrkB) agonist 7,8-dihydroxyflavone (DHF) activated the TrkB receptor to facilitate two forms of eCB-mediated synaptic depression, depolarization-induced suppression of inhibition (DSI), and long-term depression (I-LTD) of IPSCs in ventral tegmental area dopamine neurons in mouse midbrain slices. The facilitation appears to be mediated by an increase in eCB production via phospholipase Cγ pathway, but not by an increase in CB1 receptor responsiveness or a decrease in eCB hydrolysis. Using Cre-loxP technology to specifically delete BDNF in dopamine neurons, we showed that eCB-mediated I-LTD, cocaine-induced reduction of GABAergic inhibition, and potentiation of glutamatergic excitation remained intact in wild-type control mice, but were impaired in BDNF conditional knock-out mice. We also showed that cocaine-induced conditioned place preference was attenuated in BDNF conditional knock-out mice, in vivo pretreatments with DHF before place conditioning restored cocaine conditioned place preference in these mice, and the behavioral effect of DHF was blocked by a CB₁ receptor antagonist. Together, these results suggest that BDNF in dopamine neurons regulates eCB responses, cocaine-induced synaptic plasticity, and associative learning.

Keywords: BDNF; DSI; I-LTD; cocaine; conditioned place preference; endocannabinoid.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain-Derived Neurotrophic Factor / genetics
  • Brain-Derived Neurotrophic Factor / metabolism*
  • Brain-Derived Neurotrophic Factor / pharmacology
  • Carbazoles / pharmacology
  • Cocaine / pharmacology
  • Conditioning, Operant / drug effects
  • Conditioning, Operant / physiology
  • Dopamine Plasma Membrane Transport Proteins / genetics
  • Dopamine Plasma Membrane Transport Proteins / metabolism
  • Dopamine Uptake Inhibitors / pharmacology
  • Dopaminergic Neurons / drug effects
  • Dopaminergic Neurons / physiology*
  • Endocannabinoids / metabolism*
  • Enzyme Inhibitors / pharmacology
  • In Vitro Techniques
  • Indole Alkaloids / pharmacology
  • Mesencephalon / cytology*
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Neuronal Plasticity / drug effects*
  • Neuronal Plasticity / genetics
  • Piperidines / pharmacology
  • Pyrazoles / pharmacology
  • RNA, Untranslated / genetics
  • RNA, Untranslated / metabolism
  • Receptors, Glutamate / metabolism
  • Signal Transduction / drug effects
  • Signal Transduction / physiology
  • Synapses / drug effects
  • Synapses / physiology*
  • Time Factors

Substances

  • Brain-Derived Neurotrophic Factor
  • Carbazoles
  • Dopamine Plasma Membrane Transport Proteins
  • Dopamine Uptake Inhibitors
  • Endocannabinoids
  • Enzyme Inhibitors
  • Gt(ROSA)26Sor non-coding RNA, mouse
  • Indole Alkaloids
  • Piperidines
  • Pyrazoles
  • RNA, Untranslated
  • Receptors, Glutamate
  • AM 251
  • staurosporine aglycone
  • Cocaine